These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27720656)

  • 1. MicroRNA-375 as a biomarker for malignant transformation in oral lesions.
    Harrandah AM; Fitzpatrick SG; Smith MH; Wang D; Cohen DM; Chan EK
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):743-752.e1. PubMed ID: 27720656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5.
    Shi W; Yang J; Li S; Shan X; Liu X; Hua H; Zhao C; Feng Z; Cai Z; Zhang L; Zhou D
    Oncotarget; 2015 Nov; 6(37):40172-85. PubMed ID: 26474386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
    Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
    Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
    Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
    Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
    Sun L; Feng J; Ma L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma.
    Gissi DB; Morandi L; Gabusi A; Tarsitano A; Marchetti C; Cura F; Palmieri A; Montebugnoli L; Asioli S; Foschini MP; Scapoli L
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
    Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
    Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of a potential prognostic biomarker, miR-155, enhances cell proliferation in patients with oral squamous cell carcinoma.
    Ni YH; Huang XF; Wang ZY; Han W; Deng RZ; Mou YB; Ding L; Hou YY; Hu QG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):227-33. PubMed ID: 24439918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
    Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
    Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder.
    Hung KF; Liu CJ; Chiu PC; Lin JS; Chang KW; Shih WY; Kao SY; Tu HF
    Oral Oncol; 2016 Feb; 53():42-7. PubMed ID: 26675284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia.
    Ries J; Vairaktaris E; Agaimy A; Bechtold M; Gorecki P; Neukam FW; Nkenke E
    Oncol Rep; 2013 Sep; 30(3):1149-56. PubMed ID: 23784518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of invadopodia markers can identify oral lesions with a high risk of malignant transformation.
    Ali A; Soares AB; Eymael D; Magalhaes M
    J Pathol Clin Res; 2021 Jan; 7(1):61-74. PubMed ID: 33001588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma.
    Metgud R; Bajaj S
    Biotech Histochem; 2016; 91(2):96-101. PubMed ID: 26529498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase C-γ1 expression correlated with cancer progression of potentially malignant oral lesions.
    Ma LW; Zhou ZT; He QB; Jiang WW
    J Oral Pathol Med; 2013 Jan; 42(1):47-52. PubMed ID: 22671975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortactin and focal adhesion kinase as predictors of cancer risk in patients with premalignant oral epithelial lesions.
    de Vicente JC; Rodrigo JP; Rodriguez-Santamarta T; Lequerica-Fernández P; Allonca E; García-Pedrero JM
    Oral Oncol; 2012 Jul; 48(7):641-6. PubMed ID: 22377015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hamster model of sequential oral oncogenesis.
    Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
    Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
    Angadi PV; Krishnapillai R
    Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
    Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
    Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions.
    Porter S; Gueiros LA; Leão JC; Fedele S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):603-611. PubMed ID: 29891084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.